Suppr超能文献

相似文献

1
Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts.
Neurosci Lett. 2012 Aug 8;523(1):35-8. doi: 10.1016/j.neulet.2012.06.036. Epub 2012 Jun 25.
4
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
Neurology. 2007 May 8;68(19):1557-62. doi: 10.1212/01.wnl.0000260963.08711.08.
5
High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism.
Neurobiol Aging. 2015 May;36(5):2004.e9-2004.e15. doi: 10.1016/j.neurobiolaging.2015.01.020. Epub 2015 Jan 30.
7
R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family.
Eur J Neurol. 2009 Jan;16(1):101-4. doi: 10.1111/j.1468-1331.2008.02356.x.
8
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.
Mov Disord. 2010 Jun 15;25(8):979-84. doi: 10.1002/mds.22947.
9
10
Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay.
Brain Res. 2021 Jan 1;1750:147167. doi: 10.1016/j.brainres.2020.147167. Epub 2020 Oct 19.

引用本文的文献

2
Nine Hereditary Movement Disorders First Described in Asia: Their History and Evolution.
J Mov Disord. 2023 Sep;16(3):231-247. doi: 10.14802/jmd.23065. Epub 2023 Jun 13.
3
Decoding hereditary spastic paraplegia pathogenicity through transcriptomic profiling.
Zool Res. 2023 May 18;44(3):650-662. doi: 10.24272/j.issn.2095-8137.2022.281.
4
Neurodegeneration with brain iron accumulation.
Handb Clin Neurol. 2018;147:293-305. doi: 10.1016/B978-0-444-63233-3.00019-1.
5
Radiological Findings of Two Sisters with Aceruloplasminemia Presenting with Chorea.
Clin Neuroradiol. 2017 Sep;27(3):385-388. doi: 10.1007/s00062-017-0573-0. Epub 2017 Mar 3.
6
Calcium-independent phospholipases A2 and their roles in biological processes and diseases.
J Lipid Res. 2015 Sep;56(9):1643-68. doi: 10.1194/jlr.R058701. Epub 2015 May 28.
7
Iron metabolism in the CNS: implications for neurodegenerative diseases.
Nat Rev Neurosci. 2013 Aug;14(8):551-64. doi: 10.1038/nrn3453. Epub 2013 Jul 3.
8
Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.
Antioxid Redox Signal. 2014 Mar 10;20(8):1324-63. doi: 10.1089/ars.2012.4931. Epub 2013 Aug 15.
9
Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).
J Neural Transm (Vienna). 2013 Apr;120(4):695-703. doi: 10.1007/s00702-012-0922-8. Epub 2012 Dec 2.

本文引用的文献

1
Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.
Hum Mol Genet. 2012 Jun 15;21(12):2646-50. doi: 10.1093/hmg/dds089. Epub 2012 Mar 2.
2
Neuroimaging features of neurodegeneration with brain iron accumulation.
AJNR Am J Neuroradiol. 2012 Mar;33(3):407-14. doi: 10.3174/ajnr.A2677. Epub 2011 Sep 15.
3
ATP13A2-related neurodegeneration (PARK9) without evidence of brain iron accumulation.
Mov Disord. 2011 Jun;26(7):1364-5. doi: 10.1002/mds.23514. Epub 2011 Apr 5.
4
A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers.
Neurobiol Dis. 2011 Jun;42(3):468-74. doi: 10.1016/j.nbd.2011.02.009. Epub 2011 Feb 26.
5
Juvenile parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation.
Eur J Paediatr Neurol. 2011 May;15(3):271-5. doi: 10.1016/j.ejpn.2011.01.001. Epub 2011 Feb 12.
6
8
Rare causes of dystonia parkinsonism.
Curr Neurol Neurosci Rep. 2010 Nov;10(6):431-9. doi: 10.1007/s11910-010-0136-0.
9
Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations.
Mov Disord. 2010 Sep 15;25(12):1929-37. doi: 10.1002/mds.22996.
10
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.
Mov Disord. 2010 Jun 15;25(8):979-84. doi: 10.1002/mds.22947.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验